Quiflox
|
80 mg
|
V/DCP/12/0075
|
KRKA, d.d., Novo mesto, Slovēnija
|
QJ01MA93
|
dogs
|
Vairāk
|
Medicinal product information
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/DCP/12/0075-01 |
80 mg |
2 |
OPA/Al/PVH-Al blisteris, 6 tablete |
-
|
V/DCP/12/0075-02 |
80 mg |
12 |
OPA/Al/PVH-Al blisteris, 6 tablete |
-
|
|
Quiflox
|
5 mg
|
V/DCP/12/0073
|
KRKA, d.d., Novo mesto, Slovēnija
|
QJ01MA93
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/DCP/12/0073-01 |
5 mg |
1 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
V/DCP/12/0073-02 |
5 mg |
10 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
|
Quiflox
|
20 mg
|
V/DCP/12/0074
|
KRKA, d.d., Novo mesto, Slovēnija
|
QJ01MA93
|
dogs
|
|
Medicinal product information
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/DCP/12/0074-01 |
20 mg |
1 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
V/DCP/12/0074-02 |
20 mg |
10 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
|
Quiflox
|
100 mg/ml
|
V/DCP/11/0016
|
KRKA, d.d., Novo mesto, Slovēnija
|
QJ01MA93
|
cattle; pigs
|
Vairāk
|
Medicinal product information
Pharmaceutical form: |
solution for injection
|
International name (active substance): |
Marbofloxacin
|
Distribution category: |
To be supplied only on veterinary prescription
|
Manufacturer(s) responsible for batch release |
KRKA, d.d., Novo mesto, Slovēnija
|
Date of authorisation/renewal: |
26-Jan-2016
|
Marketing authorisation valid until: |
Unlimited time period
|
Marketing authorisation procedure: |
DCP
|
Package leaflet: |
[PDF] 250116LI (26-Jun-2025)
|
Labelling text: |
[PDF] 250116M (26-Jun-2025)
|
Summary of product characteristics: |
[DOCX] 250116ZA (26-Jun-2025)
|
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/DCP/11/0016-01 |
100 mg/ml |
1 |
Stikla pudele, 50 ml |
-
|
V/DCP/11/0016-02 |
100 mg/ml |
1 |
Stikla pudele, 100 ml |
-
|
V/DCP/11/0016-03 |
100 mg/ml |
1 |
Stikla pudele, 250 ml |
-
|
|